Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esra Ozcan

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Rheumatology International|February 18, 2011
Validity and reliability of the Turkish version of the Health Assessment Questionnaire for the SpondyloarthropathiesEsra Ozcan, Ozlem Yilmaz, Ahmet Tutoglu, et al.
The Journal of Allergy and Clinical Immunology|September 28, 2011
Reply to NarraEsra Ozcan, Raif S Geha, Luigi D Notarangelo
The Journal of Allergy and Clinical Immunology|December 17, 2008
Primary immune deficiencies with aberrant IgE productionEsra Ozcan, Luigi D Notarangelo, Raif S Geha
JPMA. the Journal of the Pakistan Medical Association|September 29, 2017
Pentoxifylline and Pentaglobin adjuvant therapies for neonatal nosocomial sepsis in neonates less than 1500g weightSahin Hamilcikan, Emrah Can, Ovgu Buke, et al.
Rheumatology International|September 8, 2012
Health-related quality of life in Turkish patients with ankylosing spondylitis: impact of peripheral involvement on quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioningOzlem Yılmaz, Ahmet Tutoğlu, Yeşim Garip, et al.
Current Opinion in Allergy and Clinical Immunology|November 4, 2008
Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiencyJohn J Lee, Esra Ozcan, Ingrid Rauter, et al.
The Journal of Allergy and Clinical Immunology|July 12, 2011
Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activationEsra Ozcan, Ingrid Rauter, Lilit Garibyan, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|August 24, 2020
Cascade screening and treatment of children with familial hypercholesterolemia in TurkeyEngin Kose, Melis Kose, Sureyya Ipek Ozturk, et al.
The Journal of Allergy and Clinical Immunology|August 11, 2007
Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiationEmanuela Castigli, Stephen A Wilson, Abdallah Elkhal, et al.
Brazilian Journal of Cardiovascular Surgery|July 3, 2026
The Effect of Preoperative Hydration on Cardiac Surgery-Associated Acute Kidney InjuryAyse Zehra Karakoc, Esra Ozcan, Omer Faruk Akardere, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Rheumatology International|February 18, 2011
Validity and reliability of the Turkish version of the Health Assessment Questionnaire for the SpondyloarthropathiesEsra Ozcan, Ozlem Yilmaz, Ahmet Tutoglu, et al.
The Journal of Allergy and Clinical Immunology|September 28, 2011
Reply to NarraEsra Ozcan, Raif S Geha, Luigi D Notarangelo
The Journal of Allergy and Clinical Immunology|December 17, 2008
Primary immune deficiencies with aberrant IgE productionEsra Ozcan, Luigi D Notarangelo, Raif S Geha
JPMA. the Journal of the Pakistan Medical Association|September 29, 2017
Pentoxifylline and Pentaglobin adjuvant therapies for neonatal nosocomial sepsis in neonates less than 1500g weightSahin Hamilcikan, Emrah Can, Ovgu Buke, et al.
Rheumatology International|September 8, 2012
Health-related quality of life in Turkish patients with ankylosing spondylitis: impact of peripheral involvement on quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioningOzlem Yılmaz, Ahmet Tutoğlu, Yeşim Garip, et al.
Current Opinion in Allergy and Clinical Immunology|November 4, 2008
Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiencyJohn J Lee, Esra Ozcan, Ingrid Rauter, et al.
The Journal of Allergy and Clinical Immunology|July 12, 2011
Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activationEsra Ozcan, Ingrid Rauter, Lilit Garibyan, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|August 24, 2020
Cascade screening and treatment of children with familial hypercholesterolemia in TurkeyEngin Kose, Melis Kose, Sureyya Ipek Ozturk, et al.
The Journal of Allergy and Clinical Immunology|August 11, 2007
Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiationEmanuela Castigli, Stephen A Wilson, Abdallah Elkhal, et al.
Brazilian Journal of Cardiovascular Surgery|July 3, 2026
The Effect of Preoperative Hydration on Cardiac Surgery-Associated Acute Kidney InjuryAyse Zehra Karakoc, Esra Ozcan, Omer Faruk Akardere, et al.
Pageof 2